136 related articles for article (PubMed ID: 144506)
1. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.
Zurier RB; Damjanov I; Sayadoff DM; Rothfield NF
Arthritis Rheum; 1977; 20(8):1449-56. PubMed ID: 144506
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E treatment of NZB/NZW mice.
Zurier RB; Sayadoff DM; Torrey AB; Rothfield NF
Arthritis Rheum; 1977 Mar; 20(2):723-8. PubMed ID: 300626
[TBL] [Abstract][Full Text] [Related]
3. Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.
Hurd ER; Johnston JM; Okita JR; MacDonald PC; Ziff M; Gilliam JW
J Clin Invest; 1981 Feb; 67(2):476-85. PubMed ID: 6450777
[TBL] [Abstract][Full Text] [Related]
4. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
5. Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.
Steinberg BJ; Smathers PA; Frederiksen K; Steinberg AD
J Clin Invest; 1982 Sep; 70(3):587-97. PubMed ID: 6980900
[TBL] [Abstract][Full Text] [Related]
6. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
[TBL] [Abstract][Full Text] [Related]
7. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
[TBL] [Abstract][Full Text] [Related]
8. Genetic studies on the skin lupus band test in New Zealand mice.
Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
[TBL] [Abstract][Full Text] [Related]
9. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
[TBL] [Abstract][Full Text] [Related]
10. Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus.
Izui S; Kelley VE; McConahey PJ; Dixon FJ
J Exp Med; 1980 Dec; 152(6):1645-58. PubMed ID: 6969775
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
12. Treatment of NZB/W ("lupus") mice with 15(S)-15 methyl PGE1.
Zurier RB; Gionfriddo M; Miller P
Prostaglandins Med; 1980 Apr; 4(4):281-4. PubMed ID: 7394067
[TBL] [Abstract][Full Text] [Related]
13. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide protection in NZB/NZW disease. Mechanisms and therapeutic regimens.
Morris AD; Esterly J; Chase G; Sharp GC
Arthritis Rheum; 1976; 19(1):49-55. PubMed ID: 130137
[TBL] [Abstract][Full Text] [Related]
16. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.
Yoshiki T; Mellors RC; Strand M; August JT
J Exp Med; 1974 Oct; 140(4):1011-27. PubMed ID: 4279268
[TBL] [Abstract][Full Text] [Related]
17. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
18. Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice.
Morgan AG; Steward MW
Clin Exp Immunol; 1976 Oct; 26(1):133-6. PubMed ID: 137092
[TBL] [Abstract][Full Text] [Related]
19. Alteration of lymphocyte function in NZB/NZW mice. IV. Response to levamisole.
Hahn BH; Knotts LL
Arthritis Rheum; 1979 Mar; 22(3):236-42. PubMed ID: 33681
[TBL] [Abstract][Full Text] [Related]
20. Genetic contributions to lupus-like disease in NZB/NZW mice.
Kotzin BL; Palmer E
Am J Med; 1988 Dec; 85(6A):29-31. PubMed ID: 3264457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
